Abstract
Several 4-substituted 1,3,5-triazino[1,2-a]benzimidazol-2-amines were prepared via cyclization of 2-benzimidazolylguanidine with various reactants. The prototropic tautomerism in the obtained dihydro analogs was investigated. According to the NMR data, the 3,4-dihydro form was found to predominate in DMSO solutions. All tested compounds inhibited the activity of mammalian dihydrofolate reductase. The most active compound was 4,4-dimethyl-3,4-dihydro[1,3,5]triazino[1,2-a]benzimidazol-2-amine (IC50 = 10.9 mM).
Similar content being viewed by others
References
R. L. Then, J. Chemother. (Firenze, Italy), 16(1), 3–12 (2004).
R. G. Ridley, Proc. Natl. Acad. Sci. USA, 99(21), 13362–13364 (2002).
I. H. Gilbert, Biochim. Biophys. Acta, 1587(2–3), 249–257 (2002).
E. M. Berman and L. M. Werbel, J. Med. Chem., 34(2), 479–485 (1991).
A. Gangjee and H. D. Jain, Curr. Med. Chem.: Anti-Cancer Agents, 4(5), 405–410 (2004).
I. M. Kompis, K. Islam, and R. L. Then, Chem. Rev., 105(2), 593–620 (2005).
Japanese Patent No. 10310356 (1998); Chem. Abstr., 130, 62956 (1999).
T. Toyoda, R. K. B. Brobey, G. I. Sano, et al., Biochem. Biophys. Res. Commun., 235, 515–519 (1997).
B. Roth and J. J. Burchall, Methods Enzymol., 18(Pt. B), 779–786 (1971).
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 41, No. 9, pp. 17–19, September, 2007.
Rights and permissions
About this article
Cite this article
Dolzhenko, A.V., Chui, W.K. Synthesis and biological activity of 1,3,5-triazino[1,2-a]benzimidazol-2-amines. Pharm Chem J 41, 470–473 (2007). https://doi.org/10.1007/s11094-007-0103-5
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11094-007-0103-5